ROCKLAND, Mass., April 17 /PRNewswire/ -- Fertility LifeLines(TM) and Conceive Magazine today released new survey data illustrating the need for resources for women seeking information about fertility health. The survey, supported by a leading fertility company EMD Serono, looked at unfulfilled needs of women and couples seeking information on infertility and provides new insights into the emotional impact of infertility. These issues, along with tips for handling one's personal experience with infertility, are addressed in a new free booklet provided by Fertility LifeLines(TM) and Conceive Magazine entitled In The Know: What No One Tells You About Fertility.
The online survey, which was completed by 714 women, found: -- Women are waiting longer than recommended before seeking medical advice about fertility issues. It is commonly recommended that couples should seek medical help from a Fertility Specialist if they are unable to become pregnant after one year of regular, unprotected intercourse, or six months if the woman is over 35 years of age. Of all survey respondents, 64 percent have been trying to conceive for one year or more, and nearly one-third (32 percent) are waiting to seek medical help. -- Women are surprised when it happens to them. The survey found that although 86 percent of all respondents knew at least one person who had trouble getting pregnant and 40 percent knew three or more people who struggled to get pregnant, 70 percent were surprised when they had trouble initially getting pregnant themselves. -- Women experience an emotional rollercoaster when it comes to fertility issues. Survey respondents reported feeling stress (52 percent), jealousy of other people's happy baby news (44 percent) and depressed or sad (41 percent), most of the time. They also reported that they felt fear (78 percent), anger (77 percent) and loss of control (54 percent) at least some of the time. "This survey found that there is a great need to provide women additional information on how to handle the emotional and financial stresses associated with experiencing infertility," said Kim Hahn, founder and CEO, Conceive. "The goal of the In The Know booklet was to address those and the many issues surrounding fertility concerns in a quick read, written in a friendly, candid, girlfriend-to-girlfriend style." The In The Know: What No One Tells You About Fertility booklet covers topics such as an overview of treatment options, tips on handling the additional stress in your relationship, working with your doctor to determine your treatment plan including financial considerations and talking to your partner about your concerns. Alice D. Domar, Ph.D., Assistant Professor at Harvard Medical School, Founder and Director of the Domar Center for Mind/Body Health at Boston IVF, acclaimed author and the "Fertility Goddess" according to Vogue, wrote the foreword to the In The Know booklet. "With current medical advances in fertility treatments, women are having more success getting pregnant today than they were just 10 years ago," said Dr. Domar. "Unfortunately, women are waiting longer than necessary to seek medical help because they are concerned with both the emotional and financial impact of treatment. The In The Know booklet is a great resource for these women." Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse, or six months if the woman is over 35 years of age. It affects about six million Americans, which represents about one in seven couples in their childbearing years. The majority of patients who complete treatment succeed in having a child. Where Are Women Getting Infertility Information and Advice? According to the survey, in addition to their healthcare provider more than 50 percent of women get information from health and women's magazines and 78 percent get information from Web sites and blogs. Women also seek information from girlfriends (42 percent), support groups (18 percent), family members (23 percent) and their partner (20 percent). Only about half of survey respondents felt that the available information on infertility is sufficient; of the remainder:
-- 23 percent felt there wasn't enough information on emotional issues. -- 22 percent needed additional information on dealing with stress. -- 22 percent wanted more male-oriented information. "As a company, we are committed to providing women and couples with knowledge they can use at every step throughout their fertility journey," said Jim Hoyes, Chief Commercial Officer, EMD Serono, Inc. "We will continue to invest in programs and resources that allow patients access to an array of educational materials like the In The Know guide and Fertility LifeLines(TM)." Women and healthcare providers can order a complimentary copy of In The Know: What No One Tells You About Fertility by registering at www.FertilityLifeLines.com or by calling Fertility LifeLines(TM) at 1-866-LETS-TRY (1-866-538-7879). About the Survey Fertility LifeLines(TM) and Conceive Magazine co-sponsored a survey answered by 714 women about their experience with fertility concerns. The survey took place over a five week time period from 12/21/07 to 01/25/08. The average age of the women surveyed was approximately 35 years. The survey was posted on the Survey Monkey Web site and distributed to over 6,300 women. About Fertility LifeLines(TM) Fertility LifeLines(TM) is a free and confidential educational service offering customized information and support to people with fertility health concerns, provided by EMD Serono. Fertility LifeLines(TM) is available by calling toll-free 1-866-LETS-TRY (1-866-538-7879), or via the Web at www.FertilityLifeLines.com. It is staffed with highly trained customer service representatives, infertility nurses and benefits specialists ready to assist callers with: general infertility information, insurance assistance, local Fertility Specialist referral, EMD Serono product support, and emotional support through compassionate listening to help put the patient journey into perspective and provide information about additional support and resources. About Conceive Conceive provides information and inspiration for women who have embarked on the journey to parenthood. In print (Conceive Magazine and books, including the new The Fertility Journal, A Day-by-Day Guide to Getting Pregnant and Fertility Facts, Hundreds of Tips for Getting Pregnant), online (www.conceiveonline.com) and on the air (Conceive's weekly Internet radio show, Conceive On-Air), Conceive thoroughly covers the topic of family- building, including preconception health, fertility and infertility, natural conception and fertility treatments, and adoption. Through all available media outlets, Conceive provides accurate and crucial information for women in this exciting stage of their lives. About EMD Serono, Inc. EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. EMD Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) Prefilled Syringe (choriogonadotropin alfa injection). The company has strong market positions in neurodegenerative diseases, with Rebif(R) (interferon beta-1a), as well as in endocrinology, with Saizen(R) [somatropin (rDNA origin) for injection], Serostim(R) [somatropin (rDNA origin) for injection] and Zorbtive(TM) [somatropin (rDNA origin) for injection]. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with more than 850 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts. For more information, please visit www.emdserono.com About Merck KGaA Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that began in 1668, and a future shaped by 30,968 employees in 60 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since. For more information, please visit www.merck.de
SOURCE EMD Serono, Inc.